Naprobin 50mg Injection
MRP: ₹7,500.00
Packaging
INJECTION
Composition
Fludarabine 50mg
Company
Miracauls
MRP: ₹7,500.00
Packaging
INJECTION
Composition
Fludarabine 50mg
Company
Miracauls
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Fludaphos 50mg Injection | Bharat Serum & Vaccines | ₹5,557.00 | Save ₹1,943.00 |
| Fludacel 50mg Injection | Celon Labs | ₹6,500.00 | Save ₹1,000.00 |
| Fludocyte 50mg Injection | Intas | ₹10,277.00 | — |
| Fludabine 50mg Inj. | United Biotech | ₹10,500.00 | — |
Fever, chills, cough, dyspnoea, pneumonia; GI disturbances, stomatitis; oedema; tumour lysis syndrome; skin rashes; haemolytic anaemia, haemorrhagic cystitis; neurological disturbances including peripheral neuropathy, agitation, confusion, visual disturbances and coma. Progressive encephalopathy and blindness (high doses). Potentially Fatal: Myelosuppression. Fatal autoimmune haemolytic anemia.
Co-administration with pentostatin may lead to pulmonary toxicity. Reduced metabolic activation of fludarabine with cytarabine. Reduced therapeutic efficacy with dipyridamole and other adenosine uptake inhibitors.
Renal impairment (CrCl <30 mL/min); decompensated haemolytic anaemia. Pregnancy and lactation. Concomitant use of live vaccines.
Fludarabine is rapidly dephosphorylated to 2-fluoro-ara-A and then phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP which inhibits DNA polymerase and ribonucleotide reductase resulting in inhibition of DNA synthesis leading to cell death. Metabolism: IV: Fludarabine phosphate is rapidly dephosphorylated in the serum to fludarabine which enters the tumor cells to be rephosphorylated to the active triphosphate derivative. Excretion: Mostly in the urine, about 60% of dose is excreted within 24 hr.
Routine monitoring of blood counts and Hb conc. Monitor for signs of autoimmune haemolytic anaemia; elderly. Avoid contact with skin and eyes; avoid inhalation. Myelosuppression may be cumulative and severe increasing risk of opportunistic infections. Increased risk of tumour lysis syndrome in patients with high tumour burden.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| 4-Epeedo 10 Inj. | INJECTION | ₹0.00 |
| 4-Epeedo 50 Inj. | INJECTION | ₹0.00 |
| Abingem 1000mg Inj | INJECTION | ₹6,200.00 |
| Abingem-1.4g Inj. | INJECTION | ₹0.00 |
| Abingem-200mg Inj. | INJECTION | ₹1,340.00 |
| Arzi 100mg Inj. | INJECTION | ₹310.00 |
| Arzi 200mg Inj. | INJECTION | ₹540.00 |
| Arzi 500mg Inj. | INJECTION | ₹1,000.00 |
| Cancyt 1 gm Injection | INJECTION | ₹990.00 |
| Cancyt 100 mg Injection | INJECTION | ₹175.00 |
| Cancyt 500 mg Injection | INJECTION | ₹575.00 |
| Cisteen-10mg Inj. | INJECTION | ₹82.00 |
| Cisteen-50mg Inj. | INJECTION | ₹310.00 |
| Daunocin-20mg Inj. | INJECTION | ₹0.00 |
| Emzolam 250mg Capsule 5s | CAP | ₹20,391.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist